Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
November-2014 Volume 10 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2014 Volume 10 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Effects of lentiviral infection of mesenchymal stem cells on the expression of octamer transcription factor 4

  • Authors:
    • Jing Chang
    • Li Tang
    • Han Lei
    • Xiao-Gang Zhang
    • Zhong Zuo
    • Wei Huang
    • Hang Fu
  • View Affiliations / Copyright

    Affiliations: Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China
    Copyright: © Chang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].
  • Pages: 2249-2254
    |
    Published online on: August 21, 2014
       https://doi.org/10.3892/mmr.2014.2505
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The present study aimed to investigate the effects of lentiviral infection of human umbilical cord mesenchymal stem cells (hUCMSCs) on the expression of octamer transcription factor 4 (Oct4). hUCMSCs were infected with lentivirus carrying the green fluorescent protein gene (GFP) at different multiplicities of infection (MOI), and the optimal MOI was determined by flow cytometry; the proliferation of non‑infected and GFP-carrying lentivirus‑infected hUCMSCs was evaluated by the MTT assay; and the expression of the Oct4 gene was measured by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and immunofluorescence staining in hUCMSCs cultured in vitro for eight weeks. Positive GFP staining of hUCMSCs was estimated at >75% at 48 h following infection with the GFP-carrying lentivirus (MOI = 20); no effect on hUCMSC proliferation was detected by the MTT assay following the infection; immunofluorescence analysis detected positive Oct4 expression in the cell nuclei at two and eight weeks of culture, while the relative expression of Oct4 assessed by qRT-PCR was 0.9075±0.0124. The GFP gene carried by the lentivirus was successfully expressed in hUCMSCs and had no significant effect on Oct4 expression, which lays a solid foundation for future studies investigating gene functions via the use of exogenous markers.

Introduction

Stem cell research is an emerging and actively studied topic in life sciences. Despite the pluripotency of embryonic stem cells (ESCs), their use is currently limited, largely due to ethical issues. Since 2006, transformation of fibroblasts into pluripotent cells has been successfully induced by introduction of four genes: Oct4, Sox2, c-Myc and Klf4. The resulting induced pluripotent stem (iPS) cells, have a high similarity with ESCs in morphology, proliferation, surface marker and gene expression profiles, and differentiation potential (1,2). Since then, a novel method to efficiently induce transformation of skin cells into iPS cells was also identified, involving introduction of the microRNA (mir) that is regulated by the the Oct4 and Sox2 transcription factors, miR-302 (3–5).

Human umbilical cord mesenchymal stem cells (hUCMSC), are a type of adult stem cells with multidirectional differentiation potential that can differentiate into cardiomyocytes (6), vascular endothelial cells and osteoblasts (7), etc.; this type of mesenchymal stem cells (MSCs) is widely used in research and clinical applications.

The octamer transcription factor 4 (Oct4), also known as Oct3/4 or Pou5fl (POU domain, class 5, transcription factor 1) is a homeodomain transcription factor of the POU family, and the most important transcriptional regulator of self-renewal and differentiation in ESCs. Oct4 is considered a key factor of the stem cellmultidirectional differentiation potential (8).

In this study, we infected hUCMSCs with a lentivirus that carries the green fluorescent protein gene (GFP) to assess its effects on Oct4 expression and explore the optimal conditions for future transfections of hUCMSCs with the GFP-conjugated exogenous mir-302.

Materials and methods

hUCMSC isolation and cultures

Five centimeters of the umbilical cord were collected from full-term newborns delivered by caesarean section. Informed consent of the mother, who faced no complications throughout pregnancy was obtained. The umbilical cord was immersed in a sterile culture flask containing Dulbecco’s modified Eagle’s medium (DMEM)/F12 (Gibco-BRL, Grand Island, NY, USA) and was placed on a clean bench; the arteries, veins and Wharton’s jelly were removed from the umbilical cord, followed by washing with normal saline to remove residual blood. Next, the umbilical cord was cut into 1-mm3 pieces and seeded in a culture flask within a small volume of DMEM/F12 medium containing 10% fetal bovine serum (FBS). The flask was placed in a 37ºC incubator for 30 min; then, part of the medium was added into wet tissue pieces, which were incubated in a humidified 37ºC, 5% CO2 incubator. Half of the culture medium was replaced three days later and cell growth was observed daily under an inverted microscope.

Lentivirus packaging

A lentivirus packaging system, including pLenO-DCE-Puro, pRSV-Rev, pMDlg-pRRE and pMD2.G was purchased from (Invitrogen, Carlsbad, CA, USA). HEK-293T cells (Invitrogen) were cultured until 60–70% confluence was reached, then washed with PBS twice, isolated by treating with 0.25% trypsin containing 0.01% EDTA (Sigma, St. Louis, USA) for 6–7 minutes. Cells were counted with a hemocytometer and 2×106 were seeded into 10-cm2 petri dishes and incubated overnight in a 37ºC incubator with 5% CO2. The medium was changed when the cells had reached 60–70% confluence. The 10 μl plasmid (pRSV-Rev, pMFlg-pRRE and pMD2.G; Invitrogen) and 3 μl calcium phosphate (Sigma, St. Louis, MO, USA) mixture was transferred in medium containing monolayer cells and was gently mixed; the medium was changed after 6 h of culture. The supernatant containing the virus was collected 48 h following the infection and centrifuged at 1,000 × g for 10 min at 4°C; the supernatant was passed through a 0.45-μm filter. Following a new centrifugation at 6,000 × g for 2 h at 4°C, the pellet containing the virus was dissolved in serum-free culture medium, aliquoted and stored at −70°C prior to further use.

Lentivirus titer determination

One day before measurement, HEK-293T cells were seeded into 96-well plates with 100 μl of culture medium in each well. The lentivirus was serially diluted over the wells of the plate; 8 μf/μl polybrene (Sigma) was simulteneously added to increase the efficiency of infection. Cell growth was observed two days later and the cells were collected for subsequent titer determination.

Measurement of infection efficiency

hUCMSCs at passage 3 were isolated as described, seeded into 24-well plates (5×104 cells/well) containing DMEM/F12 medium supplemented with 10% FBS, and incubated in a 37°C incubator with 5% CO2. Lentivirus [multiplicity of infection (MOI)=0, 5, 10, 15, 20; triplicates for each MOI value] was added to the wells when the cells had reached 70–80% confluence. The medium was changed 24 h following the infection and the fluorescence intensity was measured after 24, 48, 72 and 96 h. Non-infected hUCMSCs were used as negative controls. The two cell groups were respectively harvested by 0.25% trypsin (Hyclone, Logan, UT, USA), digested for 2 min at room temperature and resuspended in phosphate-buffered saline (PBS) after 96 h of infection. The efficiency of infection was shown by the percentage of cells containing GFP and was calculated by the following formula: (Number of GFP positive cells/total number of cells) × 100. The cell number was determined by a BD FACSCanto II cytometer (BD Biosciences, San José, CA, USA).

MTT assay

hUCMSCs at passage 3 were isolated as described and seeded into 96-well plates (2×103 cells/well). Five wells of the non-infected and the lentivirus-infected group were used for each assay, containing PBS and an equal volume of lentivirus at a MOI of 20, respectively. At 24, 48, 72 and 96 h after the infection, 20 μl of MTT (Beyotime Institute of Biotechnology, Haimen, China) were added to each well. Following a 4-h incubation in a 37°C incubator with 5% CO2, the culture medium was removed and 100 μl of dimethyl sulfoxide were added to dissolve the formed crystals under low-speed vibration for 10 min. The optical density (OD) was measured at 490 nm with a microplate reader 680 (Bio-Rad, Hercules, CA, USA).

Quantitative reverse transcription-polymerase chain reaction (qRTPCR)

Total RNA was extracted from two- and eight-week cultures of hUCMSCs with the TRIzol reagent (Invitrogen, New York, NY, USA) following the manufacturer’s instructions. The RNA was reverse transcribed into complementary DNA (cDNA) following instructions of the Takara PrimeScript TM RT-RCR kit (DRR014A; Takara Bio, Inc., Dalian, China). The forward and reverse primers were: 5′-GTGAGAG GCAACCTGGAGAAT-3; 5′-TACAGAACCACACTCGGAC CAC-3′ for the gene Oct4 (Abcam, Cambridge, UK), and 5′-CTTTGGTATCGTGGAAGGACTC-3′; 5′-GTAGAGGCA GGGATGATGTTCT-3′ for the glyceraldehyde 3-phosphate dehydrogenase gene (GAPDH), respectively. The expected length of the amplified fragments was 118 and 132 bp, respectively. The qPCR reaction was performed with the SYBR Premix Ex Taq™ II kit (Bio-Rad, Hercules, CA, USA) using the following conditions: denaturation at 95°C for 30 sec, followed by 40 cycles of denaturation at 95°C for 5 sec, annealing at 55°C for 30 sec and elongation at 72°C for 30 sec. Analysis of the amplification and melting curves was performed after the reaction. The expression of Oct4 was calculated by the Δ (ΔCt) method (9) and was expressed relative to that of GAPDH.

Immunofluorescence

When cells in 24-well plates had reached 65–70% confluence, the culture medium was discarded. The plates were washed twice in PBS, fixation with 4% formaldehyde at room temperature for 20 min, three washes in PBS for 5 min, treatment with 0.2% Triton X-100 for 30 min, and three washes in PBS for 5 min. Next, blocking was performed in 1% bovine serum albumin for 1 h, and the blocking buffer was washed away prior to the incubation with the 100X-diluted rabbit anti-human/mouse Oct4 antibody (ab18976, Abcam) at 4°C in a humid box overnight; PBS instead of the primary antibody was used as the blank control. The plates were placed at 37°C for 30 min, followed by three PBS washes for 5 min, incubation with the 50x-diluted tetramethylrhodamine (TRITC)-labeled goat anti-rabbit secondary antibody IgG (Golden Bridge Biotechnology Co., Ltd., Beijing, China) in the dark at 37°C for 2 h, three PBS washes for 5 min, 4′,6-diamidino-2-phenylindole (DAPI) nuclear staining for 1 min and a final PBS wash for 5 min. Glass slides were mounted with glycerol and observed under a fluorescence microscope (Olympus, Tokyo, Japan).

Statistical analysis

Statistical analysis was performed with the SPSS 17.0 software (IBM, Armonk, NY, USA). Quantitative data were presented as mean ± standard deviation (χ̄ ± SD), and comparisons between groups was performed with t-tests. P<0.05 was considered to indicate significant differences.

Results

hUCMSC growth and morphology

Half of the culture medium was replaced on the third day of the culture, when most of the tissue pieces had attached to the wells, and was again changed every two days afterwards. A few fusiform hUCMSCs dissociated from the tissue (Fig. 1A) after 10 days of culture, while a high number of colonies was formed after 15 days, when hUCMSCs displayed a typical fibroblast-like spindle shape (Fig. 1B). Cells were trypsinized and were passaged after they had reached 80–90% confluence. Cell morphology and properties, such as cell cycle phase (the majority were in G0/G1 phases with only a small minority in the S phase), self-renewal, pluripotency and differentiation did not significantly change after passage 10 (Fig. 1C and D).

Figure 1

Morphology of human umbilical cord mesenchymal stem cells (hUCMSCs). (A and B) Primary culture at (A) 10 and (B) 15 days of culture; (C and D) Cells at passage 3 (C, ×100; D, ×200).

Analysis of hUCMSC surface markers

The analysis of hUCMSCs at the third passage by flow cytometry showed that CD29, D90 and CD105 are expressed in these cells (Fig. 2A–C and E), while the cells are negative for CD34 and CD45 (Fig. 2F and G), which are the surface markers of hematopoietic stem cells.

Figure 2

Expression of surface markers in human umbilical cord mesenchymal stem cells (hUCMSCs). hUCMSCs are positive for CD29, CD90 and CD105, and negative for CD34 and CD45.

Lentivirus packaging and infection efficiency

Bright green fluorescence was observed under the fluorescence microscope 48 h following infection of the HEK-293T cells (Fig. 3A and B), which indicated successful packaging of the active lentivirus. Hole-by-dilution was used to determine the virus titer and flow cytometry was employed to detect the percentage of GFP-positive cells. The titer of the GFP-carrying lentivirus was estimated at 2×108 TU/ml, which was considered suitable for infecting hUCMSCs.

Figure 3

Green fluorescent protein (GFP) expression in HEK-293T cells and in human umbilical cord mesenchymal stem cells (hUCMSCs) following infection. (A and B) HEK-293T cells 48 h following the infection. (A) Light field (x100); (B) fluorescence field (x100). (C and D) hUCMSCs following the infection [multiplicity of infection (MOI) = 20, 96 h]. (C) Light field (x100); (D) fluorescence field (x100).

Following hUCMSC infection, all cells expressed the GFP protein as shown by green fluorescence emitted at any MOI value (except MOI = 0). The cell morphology observed under the fluorescence microscope was similar to that observed under a light microscope (Fig. 3C and D).

The fluorescence intensity was the strongest at 96 h following the infection. With the increase of MOI and the proliferation of cells, fluorescence became stronger, reaching its highest level at MOI = 20. Flow cytometry analysis showed that the infection efficiency is 75.85% at MOI = 20 and at 96 h following the infection (Fig. 4).

Figure 4

Analysis of the infection efficiency by flow cytometry. (A) Non-infected group; (B) lentivirus-infected group. The infection efficiency of the lentivirus-infected group [96 h, multiplicity of infection (MOI) = 20] is markedly higher (75.82%) compared to the non-infected group (0.75%).

Cell proliferation

Cell proliferation was measured in the non-infected and the lentivirus-infected group with the MTT assay (Fig. 5), and no statistically significant difference was observed between the OD values of the two groups (P>0.05), which suggested that the GFP gene carried by the lentivirus does not markedly affect cell proliferation under the tested conditions.

Figure 5

Proliferation of cells from the infected and the non-infected group, as assessed by the MTT assay. There is no statistically significant difference in the optical density (OD) values at 490 nm between the two groups.

mRNA level of Oct4

The Oct4 expression level was defined as 1 in the lentivirus-infected group of hUCMSCs after two weeks of culture, and thus, the level of Oct4 was estimated at 0.9075±0.0124 after eight weeks of culture (Fig. 6). The relative expression of Oct4 was not significantly different between cells cultured for two and eight weeks (P>0.05).

Figure 6

Expression of the octamer transcription factor 4 gene (Oct4), as assessed by quantitative reverse transcription-polymerase chain reaction (qRT-PCR). There is no statistically significant difference in the relative expression level of Oct4 between two and eight weeks of culture.

Oct4 protein expression

Immunofluorescence revealed that the Oct4 protein is expressed in hUCMSCs of both the infected and the non-infected group. There was no statistically significant difference in the levels of Oct4 between the two groups. DAPI nuclear staining experiments revealed that the Oct4 protein is mainly distributed in the cell nuclei (Fig. 7).

Figure 7

Octamer transcription factor 4 (Oct4) expression in human umbilical cord mesenchymal stem cells (hUCMSCs) observed under a fluorescence microscope (x100). (A–C) Non-infected group; (D–F) infected group. Immunofluorescence shows that the Oct4 protein is expressed in both the infected and the non-infected group. 4′,6-diamidino-2-phenylindole (DAPI) staining shows that Oct4 mainly localizes in the cell nuclei.

Discussion

MSCs, an important member of the stem cell family, are multipotent stem cells derived from the mesoderm at the early stages of development, and show high self-renewal ability and multidirectional differentiation potential. HUCMSCs, a type of adult stem cells with multidirectional differentiation potential (10), have several advantages compared to other MSCs, including easy access and availability, high proliferation ability, low immunogenicity, and no associated ethical limitations. Moreover, hUCMSCs remain in their primitive and undifferentiated state (11–14), which renders introduction and expression of exogenous genes easy during cell proliferation; this is one reason why hUCMSCs have become the focus of numerous studies in recent years. In our experiment, we cultured umbilical cord tissue sections in order to isolate hUCMSCs.

Oct4 has been recognized as a specific marker of stem cells and a key factor for cell totipotency, which is lost during cell differentiation (15). Oct4 is not only expressed in pluripotent embryonic cells, but also in adult stem cells (16–19). Carlin et al (20) demonstrated that the embryonic stem cell markers Oct4, Sox2 and Nanog are expressed in hUCMSCs. Can et al (21) showed that the Oct4 gene is expressed in hUCMSCs, indicating that hUCMSCs possess stem cell properties.

Lentivirus is a non-oncogenic virus; in contrast to other viral vectors, it can infect dividing and non-dividing cells, especially cells that are difficult to transfect, such as primary cells, stem cells and neurons, with an infection efficiency of almost 100%. In addition, lentiviral vectors can effectively integrate, and thus allow consistent expression of, exogenous genes into the chromosome of host cells (22,23), and have attracted increasing attention in the field of gene transfer vectors (24). Miyoshi et al (25) demonstrated that GFP is a marker of infection efficiency. The lentiviral vector used in our experiment bears the GFP-encoding gene, in order to allow assessment of cell infection efficiency and optimization of the infection conditions. Lentiviral vectors may integrate close to promoters and insertion mutations, which may explain why infection with the GFP-carrying lentivirus does not affect hUCMSC proliferation. The low probability of lentivirus insertion near promoters, minimizes the occurrence of insertion mutations, which may partly explain the fact that proliferation of the infected cells was not changed.

In our experiments, the GFP gene was successfully introduced into hUCMSCs through a lentiviral vector, which provides an ideal model for subsequent research on gene infection. Green fluorescence was observed under a fluorescence microscope and was the strongest at 96 h post-infection; the cell morphology observed under the fluorescence microscope was similar to that observed under a light microscope. Flow cytometry showed that the infection efficiency was >75% at MOI = 20. The OD values from the MTT assay did not show any significant difference between the infected and the non-infected groups, which indicates that infection with a GFP-carrying lentivirus has no effect on cell proliferation. Oct4 expression was detected by qRT-PCR and immunofluorescence. qRT-PCR revealed that the Oct4 mRNA level is not significantly different between cells cultured for two and eight weeks, which implies that infection of hUCMSCs with the GFP-carrying lentivirus does not affect their pluripotency. Immunofluorescence further showed that the Oct4 protein is expressed in both infected and non-infected cells, with no apparent difference between the two groups, and is mainly expressed in the cell nuclei.

In conclusion, the GFP-carrying lentivirus can effectively infect hUCMSCs and has no prominent effect on cell pluripotency and proliferation. Our results lay a solid foundation for future research using exogenous gene-carrying vectors.

References

1 

Takahashi K and Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 126:663–676. 2006. View Article : Google Scholar : PubMed/NCBI

2 

Okita K, Ichisaka T and Yamanaka S: Generation of germline-competent induced pluripotent stem cells. Nature. 448:313–317. 2007. View Article : Google Scholar : PubMed/NCBI

3 

Lin SL, Chang DC, Lin CH, Ying SY, Leu D and Wu DT: Regulation of somatic cell reprogramming through inducible mir-302 expression. Nucleic Acids Res. 39:1054–1065. 2011. View Article : Google Scholar : PubMed/NCBI

4 

Card DA, Hebbar PB, Li L, et al: Oct4/Sox2-regulated mir-302 targets cyclin D1 in human embryonic stem cells. Mol Cell Biol. 28:6426–6438. 2008. View Article : Google Scholar : PubMed/NCBI

5 

Zovoilis A, Pantazi A, Smoraq L, et al: Embryonic stem cell-related miRNAs are involved in differentiation of pluripotent cells originating from the germ line. Mol Hum Reprod. 16:793–803. 2010. View Article : Google Scholar : PubMed/NCBI

6 

Schmidt D, Mol A, Odermatt B, et al: Engineering of biologically active living heart valve leaflets using human umbilical cord-derived progenitor cells. Tissue Eng. 12:3223–3232. 2006. View Article : Google Scholar : PubMed/NCBI

7 

Sarugaser R, Lickorish D, Baksh D, Hosseini MM and Davies JE: Human umbilical cord perivascular (HUCPV) cells: A source of mesenchymal progenitors. Stem Cells. 23:220–229. 2005.PubMed/NCBI

8 

Boyer LA, Lee TI, Cole MF, et al: Core transcriptional regulatory circuitry in human embryonic stem cells. Cell. 122:947–956. 2005. View Article : Google Scholar : PubMed/NCBI

9 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.

10 

Wang H, Yang Y, Ho G, et al: Programming of human umbilical cord mesenchymal stem cells in vitro to promote pancreatic gene expression. Mol Med Rep. 8:769–774. 2013.PubMed/NCBI

11 

Phermthai T, Odglun Y, Julavijitphong S, et al: A novel method to derive amniotic fluid stem cells for therapeutic purposes. BMC Cell Biol. 11:792010. View Article : Google Scholar : PubMed/NCBI

12 

Troyer DL and Weiss ML: Wharton’s jelly-derived cells are a primitive stromal cell population. StemCells. 26:591–599. 2008.

13 

Kim J, Lee Y, Kim H, et al: Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif. 40:75–90. 2007.PubMed/NCBI

14 

Schneider RK, Püllen A, Kramann R, et al: Long-term survival and characterisation of human umbilical cord-derived mesenchymal stem cells on dermal equivalents. Differentiation. 79:182–193. 2010. View Article : Google Scholar : PubMed/NCBI

15 

Atlasi Y, Mowla SJ, Ziaee SA and Bahrami AR: OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int J Cancer. 120:1598–1602. 2007. View Article : Google Scholar : PubMed/NCBI

16 

Hochedlinger K, Yamada Y, Beard C and Jaenisch R: Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell. 121:465–477. 2005. View Article : Google Scholar

17 

Mueller T, Luetzkendorf J, Nerger K, Schmoll HJ and Mueller LP: Analysis of OCT4 expression in an extended panel of human tumor cell lines from multiple entities and in human mesenchymal stem cells. Cell Mol Life Sci. 66:495–503. 2009. View Article : Google Scholar : PubMed/NCBI

18 

Kaltz N, Funari A, Hippauf S, et al: In vivo osteoprogenitor potency of human stromal cells from different tissues does not correlate with expression of POU5F1 or its pseudogenes. Stem Cells. 26:2419–2424. 2008. View Article : Google Scholar

19 

Lengner CJ, Camargo FD, Hochedlinger K, et al: Oct4 expression is not required for mouse somatic stem cell self-renewal. Cell Stem Cell. 1:403–415. 2007. View Article : Google Scholar : PubMed/NCBI

20 

Carlin R, Davis D, Weiss M, Schultz B and Troyer D: Expression of early transcription factors Oct-4, Sox-2 and Nanog by porcine umbilical cord (PUC) matrix cells. Reprod Biol Endocrinol. 4:82006. View Article : Google Scholar : PubMed/NCBI

21 

Can A and Karahuseyinoglu S: Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells. 25:2886–2895. 2007.

22 

Weinberg MS, Barichievy S, Schaffer L, Han J and Morris KV: An RNA targeted to the HIV-1 LTR promoter modulates indiscriminate off-target gene activation. Nucleic Acids Res. 35:7303–7312. 2007. View Article : Google Scholar : PubMed/NCBI

23 

Cockrell AS and Kafri T: Gene delivery by lentivirus vectors. Mol Biotechnol. 36:184–204. 2007. View Article : Google Scholar

24 

Peng X, Zhang X and Zeng B: Locally administered lentivirus-mediated siRNA inhibits wear debris-induced inflammation in murine air pouch model. Biotechnol Lett. 30:1923–1929. 2008. View Article : Google Scholar : PubMed/NCBI

25 

Miyoshi N, Ishii H, Nagai K, et al: Defined factors induce reprogramming of gastrointestinal cancer cells. Proc Natl Acad Sci USA. 107:40–45. 2010. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Chang J, Tang L, Lei H, Zhang X, Zuo Z, Huang W and Fu H: Effects of lentiviral infection of mesenchymal stem cells on the expression of octamer transcription factor 4. Mol Med Rep 10: 2249-2254, 2014.
APA
Chang, J., Tang, L., Lei, H., Zhang, X., Zuo, Z., Huang, W., & Fu, H. (2014). Effects of lentiviral infection of mesenchymal stem cells on the expression of octamer transcription factor 4. Molecular Medicine Reports, 10, 2249-2254. https://doi.org/10.3892/mmr.2014.2505
MLA
Chang, J., Tang, L., Lei, H., Zhang, X., Zuo, Z., Huang, W., Fu, H."Effects of lentiviral infection of mesenchymal stem cells on the expression of octamer transcription factor 4". Molecular Medicine Reports 10.5 (2014): 2249-2254.
Chicago
Chang, J., Tang, L., Lei, H., Zhang, X., Zuo, Z., Huang, W., Fu, H."Effects of lentiviral infection of mesenchymal stem cells on the expression of octamer transcription factor 4". Molecular Medicine Reports 10, no. 5 (2014): 2249-2254. https://doi.org/10.3892/mmr.2014.2505
Copy and paste a formatted citation
x
Spandidos Publications style
Chang J, Tang L, Lei H, Zhang X, Zuo Z, Huang W and Fu H: Effects of lentiviral infection of mesenchymal stem cells on the expression of octamer transcription factor 4. Mol Med Rep 10: 2249-2254, 2014.
APA
Chang, J., Tang, L., Lei, H., Zhang, X., Zuo, Z., Huang, W., & Fu, H. (2014). Effects of lentiviral infection of mesenchymal stem cells on the expression of octamer transcription factor 4. Molecular Medicine Reports, 10, 2249-2254. https://doi.org/10.3892/mmr.2014.2505
MLA
Chang, J., Tang, L., Lei, H., Zhang, X., Zuo, Z., Huang, W., Fu, H."Effects of lentiviral infection of mesenchymal stem cells on the expression of octamer transcription factor 4". Molecular Medicine Reports 10.5 (2014): 2249-2254.
Chicago
Chang, J., Tang, L., Lei, H., Zhang, X., Zuo, Z., Huang, W., Fu, H."Effects of lentiviral infection of mesenchymal stem cells on the expression of octamer transcription factor 4". Molecular Medicine Reports 10, no. 5 (2014): 2249-2254. https://doi.org/10.3892/mmr.2014.2505
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team